Discontinued — last reported Q2 '23
ResMed Saas Segment — Restructuring expenses (note 18) remained flat by 0.0% to $625.00K in Q2 2023 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
An increase suggests active operational restructuring or cost-cutting initiatives, while a decrease indicates a more stable operational environment with fewer integration or realignment activities.
This metric represents the costs incurred by the Software-as-a-Service (SaaS) business segment related to organizational...
Peers in the healthcare technology and SaaS space often report these as 'restructuring charges' or 'special items' within segment operating expenses, which are typically excluded from adjusted earnings metrics.
rmd_segment_saas_segment_restructuring_expenses_note_18| FY'23 | |
|---|---|
| Value | $2.50M |